Thrivent Financial for Lutherans
AZN icon

Thrivent Financial for Lutherans’s AstraZeneca AZN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53M Buy
282,337
+29,226
+12% +$5.5M 0.09% 273
2026
Q1 		$49.1M Buy
253,111
+233,446
+1,187% +$45M 0.09% 269
2025
Q4 		$3.63M Buy
19,665
+9,482
+93% +$1.66M 0.01% 1082
2025
Q3 		$1.56M Buy
10,183
+238
+2% +$36K ﹤0.01% 1498
2025
Q2 		$1.39M Sell
9,945
-1,545
-13% -$217K ﹤0.01% 1579
2025
Q1 		$1.49M Sell
11,490
-1,693
-13% -$245K ﹤0.01% 1450
2024
Q4 		$1.71M Sell
13,183
-9,045
-41% -$1.27M ﹤0.01% 1551
2024
Q3 		$3.46M Sell
22,228
-664,175
-97% -$107M 0.01% 1105
2024
Q2 		$107M Sell
686,403
-20,582
-3% -$3.1M 0.22% 113
2024
Q1 		$95.8M Buy
706,985
+190,919
+37% +$25.3M 0.19% 137
2023
Q4 		$69.5M Buy
516,066
+187,244
+57% +$24.3M 0.15% 193
2023
Q3 		$44.5M Sell
328,822
-1,572
-0.5% -$215K 0.11% 251
2023
Q2 		$47.3M Sell
330,394
-715,035
-68% -$105M 0.11% 243
2023
Q1 		$145M Buy
1,045,429
+418,822
+67% +$56.3M 0.35% 51
2022
Q4 		$85M Sell
626,607
-14,912
-2% -$1.87M 0.22% 120
2022
Q3 		$70.4M Buy
641,519
+1,115
+0.2% +$141K 0.19% 141
2022
Q2 		$84.6M Sell
640,404
-21,040
-3% -$2.76M 0.23% 105
2022
Q1 		$87.8M Buy
+661,444
New +$79.3M 0.17% 154
2017
Q4 		– Sell
-274
Closed -$18K – 2034
2017
Q3 		$18K Buy
+274
New +$17.3K ﹤0.01% 2090

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Thrivent Financial for Lutherans's AZN Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $5.5M and bringing the position to 282,337 shares worth $53M. The position accounts for 0.09% of the portfolio, ranked #273.

Thrivent Financial for Lutherans first reported a position in AZN in Q3 2017 and has held it in 19 quarters since. The position peaked at $145M in Q1 2023. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Thrivent Financial for Lutherans held 282,337 shares of AstraZeneca worth $53M as of Q2 2026.
  • Thrivent Financial for Lutherans bought 29,226 AstraZeneca shares in Q2 2026, an estimated $5.5M.
  • AstraZeneca made up 0.09% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #273 holding.
  • Thrivent Financial for Lutherans first reported a position in AstraZeneca in Q3 2017 and has held it in 19 quarters since.
  • Thrivent Financial for Lutherans's AstraZeneca position peaked at $145M in Q1 2023.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.